PP
TECH icon

Pegasus Partners’s Bio-Techne TECH Stock Holding History

Pegasus Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,892
Closed -$205K – 145
2022
Q1 		$205K Sell
1,892
-316
-14% -$32.6K 0.04% 130
2021
Q4 		$286K Sell
2,208
-496
-18% -$60.8K 0.05% 120
2021
Q3 		$328K Sell
2,704
-940
-26% -$114K 0.06% 125
2021
Q2 		$410K Buy
3,644
+592
+19% +$62.3K 0.08% 114
2021
Q1 		$291K Buy
+3,052
New +$278K 0.06% 141

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Pegasus Partners's TECH Position: Q2 2022 in Review

Pegasus Partners sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 1,892 shares — an estimated $205K sold.

Pegasus Partners first reported a position in TECH in Q1 2021 and held it in 5 quarters. The position peaked at $410K in Q2 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Pegasus Partners reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
  • Pegasus Partners sold 1,892 Bio-Techne shares in Q2 2022, an estimated $205K.
  • Pegasus Partners first reported a position in Bio-Techne in Q1 2021 and held it in 5 quarters.
  • Pegasus Partners's Bio-Techne position peaked at $410K in Q2 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Pegasus Partners's 13F filing for Q2 2022, filed 12 Aug 2022.